Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CRISPR-Edited TIL Therapy for Gastrointestinal Cancer
Recruiting3 awardsPhase 1 & 2
Minneapolis, Minnesota
This trial is testing whether genetically-engineered TIL cells, which have been edited with CRISPR to turn off the CISH checkpoint, are safe and effective at treating GI cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.